Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | PPM1B | O75688 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.31 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | PPP5C | P53041 | 1/20 | 0.31 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6045969 | 0.81 | KDM4E (0.31) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL2470524 | 0.69 | — | — | |
| SCHEMBL375777 | 0.69 | — | — | |
| SCHEMBL4165018 | 0.65 | LMNA (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL14187990 | 0.60 | KDM4E (0.38) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL19107418 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL112827 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL21999910 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL910480 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL16923832 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119081040-A | Preparation method of chemically recyclable polyacetal and product and chemical recycling method thereof | 浙江大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118994284-A | Gemcitabine prodrug or pharmaceutically acceptable salt thereof containing side chains with different flexibilities, self-assembled nanoparticle thereof and application | 沈阳药科大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118955886-A | Carbonate functionalized polymer and synthetic method and application thereof | 华南理工大学 | 2024-11-15 | — | — | CN | claimed |
| US-20240368726-A1 | THIODIGLYCOLAMIC ACID EXTRACTANT, AND PREPARATION METHOD AND USE THEREOF | INSTITUTE OF APPLIED CHEMISTRY, JIANGXI ACADEMY OF SCIENCES (CN) | 2024-11-07 | — | — | US | claimed |
| CN-118702912-A | Preparation method of spontaneously degradable cyclic poly (ester-peptide), product and degradation method thereof | 浙江大学 | 2024-09-27 | — | — | CN | claimed |
| CN-118406203-A | Preparation method of intrinsic flame-retardant high-strength polyacetal and product thereof | 浙江大学 | 2024-07-30 | — | — | CN | claimed |
| CN-118271570-A | Preparation method of organic phosphine-terminated non-conjugated oxygen-enriched fluorescent polymer, and product and application thereof | 浙江大学 | 2024-07-02 | — | — | CN | claimed |
| CN-118184555-A | Method for synthesizing and purifying HDEHSDGA | 山东第一医科大学(山东省医学科学院) | 2024-06-14 | — | — | CN | claimed |
| CN-117736254-A | N, N-dimethyl ethylenediamine-thiodiglycolic acid mono-cholesterol ester conjugate and preparation method and application thereof | 常州大学 | 2024-03-22 | — | — | CN | claimed |
| CN-114853617-B | Extracting agent for extracting and separating neodymium (III), preparation method and application thereof | 山东大学 | 2023-12-22 | — | — | CN | claimed |
| CN-106729746-B | To the preparation method and applications of the tumor infiltrating nanosystems of the partial size shrinkage type of FAP- α enzyme, reducing environment sensitive | 郑州大学 | 2019-11-22 | — | — | CN | claimed |
| CN-106602141-B | A kind of electrolyte and secondary cell | 宁德新能源科技有限公司 | 2019-01-08 | — | — | CN | claimed |
| CN-108478794-A | The structure of photosensitizer-chemotherapeutic \" photochemical one \" small molecule prodrugs and its self-assembled nanometer grain | 沈阳药科大学 | 2018-09-04 | — | — | CN | claimed |
| CN-106729746-A | To FAP α enzymes, the preparation method and applications of the tumor infiltrating nanosystems of the particle diameter shrinkage type of reducing environment sensitive | 郑州大学 | 2017-05-31 | — | — | CN | claimed |
| CN-106602141-A | Electrolyte and secondary battery | 宁德新能源科技有限公司 | 2017-04-26 | — | — | CN | claimed |
| WO-2016116335-A1 | ENZYMATIC PROCESS FOR THE REGIOSELECTIVE MANUFACTURING OF N-FMOC-DOXORUBICIN-14-O-DICARBOXYLIC ACID MONO ESTERS | AETERNA ZENTARIS GMBH (DE) | 2016-07-28 | — | — | WO | claimed |
| US-20160208298-A1 | ENZYMATIC PROCESS FOR THE REGIOSELECTIVE MANUFACTURING OF N-FMOC-DOXORUBICIN-14-O-DICARBOXYLIC ACID MONO ESTERS | AETERNA ZENTARIS GMBH (DE) | 2016-07-21 | — | — | US | claimed |
| EP-3045540-A1 | Enzymatic process for the regioselective manufacturing of N-Fmoc-doxorubicin-14-O-dicarboxylic acid mono esters | Æterna Zentaris GmbH (DE) | 2016-07-20 | — | — | EP | claimed |
| US-4323676-A | Process for preparing cephalosporins | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-04-06 | — | — | US | claimed |
| US-4308381-A | Cephem compounds | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-12-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368726-A1 | THIODIGLYCOLAMIC ACID EXTRACTANT, AND PREPARATION METHOD AND USE THEREOF | GDA, AGL, MGAM | KDM4E 3489/4885GMNN 258/4885PPM1B 4008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.